Optas, LLC Gsk PLC Transaction History

Optas, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	BUY	$42.05 - $47.77 $23,716 - $26,942	564 Added 7.11%	8,502 $370,000
Q1 2022 Apr 26, 2022	BUY	$40.23 - $47.74 $4,022 - $4,774	100 Added 1.28%	7,938 $345,000
Q4 2021 Jan 26, 2022	SELL	$38.88 - $45.31 $194 - $226	-5 Reduced 0.06%	7,838 $345,000
Q3 2021 Oct 14, 2021	BUY	$38.79 - $43.16 $24,011 - $26,716	619 Added 8.57%	7,843 $300,000
Q2 2021 Jul 27, 2021	BUY	$36.52 - $41.46 $3,286 - $3,731	90 Added 1.26%	7,224 $287,000
Q1 2021 Apr 19, 2021	BUY	$34.27 - $40.01 $244,482 - $285,431	7,134 New	7,134 $255,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Optas, LLC, based on Form 13F filings with the SEC.

Stay updated on Optas, LLC with notifications on news.